glp 1 and cannabinoids Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies Blockade of cannabinoid 1 receptor

Clin Endocrinol 48:8187 Krzisnik C, Battelino T (1997) Five year treatment with IGF-I of a patient with Laron syndrome in Slovenia (a follow-up report)

However, patients taking multiple antihypertensive medications should have their blood pressure monitored regularly, as excessive lowering could potentially cause symptomatic hypotension, particularly in elderly patients or those with autonomic dysfunction

Therefore, elucidating whether the cGAS-STING-ferroptosis pathway is involved in RA-associated inflammation and cartilage damage and determining whether GLP-1RAs provide multi-target protection to RA by inhibiting this pathway, may provide novel theoretical insights and therapeutic strategies for RA management

Accordingly, a safer and more effective treatment needs to be developed

J Nutraceuticals, Funct Med Foods